A carregar...
Comparison of Real-World Outcomes of Infliximab versus Adalimumab in Biologic-Naïve Korean Patients with Ulcerative Colitis: A Population-Based Study
PURPOSE: Data on the comparative effectiveness of infliximab (IFX) or adalimumab (ADA) in patients with ulcerative colitis (UC) are extremely limited, especially in the Asian population. We compared clinically important outcomes [colectomy, UC-related emergency room (ER) visits, UC-related hospitali...
Na minha lista:
| Publicado no: | Yonsei Med J |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Yonsei University College of Medicine
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6938779/ https://ncbi.nlm.nih.gov/pubmed/31887799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2020.61.1.48 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|